Absci Corp (ABSI) — SEC Financial Statements & Analysis

Absci Corp (ABSI) is a services-commercial physical & biological research company. Absci Corp trades on Nasdaq as: ABSI. Absci Corp (ABSI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Absci Corp carries a market cap of $1.83B, a P/E ratio of -15.07x, a P/B ratio of 7.42x, a P/S ratio of 1169.18x, an enterprise value of $1.72B, and an EV/EBITDA multiple of -14.91x. On profitability, it posts a gross margin of 116.18%, an operating margin of -8084.50%, a net margin of -7756.37%, a Return on Equity (ROE) of -57.72%, a Return on Assets (ROA) of -50.57%, and a Return on Invested Capital (ROIC) of -97.94%. Per share, it reports EPS of $-0.77, diluted EPS of $-0.77, free cash flow per share of $-0.69, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -62.28% year-over-year, net income growth of 6.87% year-over-year, and EPS growth of -13.41% year-over-year. On the balance sheet, it maintains a current ratio of 10.63x, a quick ratio of 10.26x, working capital of $188.67M, a debt-to-equity ratio of 0.09x, a debt ratio of 0.08, an interest coverage ratio of -1342.54x, free cash flow of $-109.18M (TTM), and net debt of $-108.77M. Figures sourced from SEC EDGAR.

Market Cap

$1.83B

P/E TTM

-15.07x

EPS TTM

$-0.77

P/B TTM

7.42x

ROE TTM

-57.72%

ROA TTM

-50.57%

Debt To Equity

0.09x

Free Cash Flow TTM

$-109.18M

Net Revenue TTM Growth 1Y

-62.28%

Data as of 2026-06-30 · Source: SEC EDGAR